Burden of arthritis, long-term back problems and osteoporosis in Western Australia projected in report

The number of people living with arthritis in Western Australia is projected to increase significantly by 2045, suggests a new Monash University led-report, in collaboration with Curtin University, ...
BioWorld

Australia’s Cynata ahead of the pack as it progresses iPSCs to phase III osteoarthritis trial

PERTH, Australia – Melbourne-based regenerative medicine company Cynata Therapeutics Ltd. is gearing up to take its Cymerus mesenchymal stem cell (MSC) product candidate, CYP-004, into a phase III ...
Wane

Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up

MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharmaceuticals Ltd (ASX:PAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium (iPPS) ...